Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
$97.77
-3.9%
$106.55
$55.92
$128.52
$3.19B1.36472,010 shs260,902 shs
Envista Holdings Co. stock logo
NVST
Envista
$16.21
-3.2%
$20.04
$15.15
$23.00
$2.79B1.332.28 million shs2.78 million shs
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$56.03
-2.7%
$71.15
$45.56
$103.81
$3.07B1.06719,057 shs996,207 shs
RxSight, Inc. stock logo
RXST
RxSight
$25.22
-3.3%
$30.76
$24.64
$66.54
$1.02B1.22526,243 shs291,254 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
-3.85%-3.57%-8.53%+13.12%-6.67%
Envista Holdings Co. stock logo
NVST
Envista
-3.10%-9.14%-22.98%-16.76%-25.49%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-2.71%-7.51%-15.11%-37.21%+11.66%
RxSight, Inc. stock logo
RXST
RxSight
-3.26%-1.33%-21.65%-32.39%-48.26%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
1.4993 of 5 stars
3.41.00.00.02.40.00.6
Envista Holdings Co. stock logo
NVST
Envista
4.221 of 5 stars
3.04.00.03.91.80.02.5
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.9651 of 5 stars
3.43.00.00.03.12.50.6
RxSight, Inc. stock logo
RXST
RxSight
2.7395 of 5 stars
3.42.00.00.02.63.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
2.82
Moderate Buy$119.7322.46% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.07
Hold$20.1824.51% Upside
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$94.2968.28% Upside
RxSight, Inc. stock logo
RXST
RxSight
2.75
Moderate Buy$51.63104.70% Upside

Current Analyst Ratings Breakdown

Latest RXST, PRCT, IRTC, and NVST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/10/2025
Envista Holdings Co. stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$23.00 ➝ $21.00
3/8/2025
Envista Holdings Co. stock logo
NVST
Envista
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$19.00
3/6/2025
Envista Holdings Co. stock logo
NVST
Envista
New Street Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$19.00
3/6/2025
Envista Holdings Co. stock logo
NVST
Envista
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$20.00 ➝ $19.00
3/6/2025
Envista Holdings Co. stock logo
NVST
Envista
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$20.00 ➝ $19.00
3/6/2025
Envista Holdings Co. stock logo
NVST
Envista
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
2/26/2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$105.00 ➝ $95.00
2/26/2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$105.00 ➝ $90.00
2/26/2025
RxSight, Inc. stock logo
RXST
RxSight
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$62.00 ➝ $40.00
2/26/2025
RxSight, Inc. stock logo
RXST
RxSight
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$35.00 ➝ $33.00
2/26/2025
RxSight, Inc. stock logo
RXST
RxSight
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$40.00 ➝ $35.00
(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
$591.84M5.19N/AN/A$6.85 per share14.27
Envista Holdings Co. stock logo
NVST
Envista
$2.51B1.11$1.26 per share12.91$17.04 per share0.95
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$224.50M13.68N/AN/A$5.56 per share10.08
RxSight, Inc. stock logo
RXST
RxSight
$139.93M7.30N/AN/A$4.47 per share5.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
-$123.41M-$3.64N/AN/AN/A-19.14%-118.83%-11.34%5/1/2025 (Estimated)
Envista Holdings Co. stock logo
NVST
Envista
-$1.12B-$6.49N/A13.391.27-44.56%3.86%2.21%5/7/2025 (Estimated)
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$105.90M-$1.76N/AN/AN/A-50.07%-38.57%-26.06%5/7/2025 (Estimated)
RxSight, Inc. stock logo
RXST
RxSight
-$48.61M-$0.72N/AN/AN/A-23.92%-14.00%-12.51%5/5/2025 (Estimated)

Latest RXST, PRCT, IRTC, and NVST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/25/2025Q4 2024
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.34-$0.35-$0.01-$0.35$66.79 million$68.24 million
2/25/2025Q4 2024
RxSight, Inc. stock logo
RXST
RxSight
$0.10-$0.15-$0.25-$0.15$40.23 million$40.21 million
2/20/2025Q4 2024
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
-$0.29$0.01+$0.30-$0.04$158.30 million$164.33 million
2/5/2025Q4 2024
Envista Holdings Co. stock logo
NVST
Envista
$0.23$0.24+$0.01$0.01$646.28 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
9.00
6.27
6.12
Envista Holdings Co. stock logo
NVST
Envista
0.44
2.04
1.76
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.21
6.02
5.07
RxSight, Inc. stock logo
RXST
RxSight
N/A
12.67
11.71

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
N/A
Envista Holdings Co. stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
89.46%
RxSight, Inc. stock logo
RXST
RxSight
78.78%

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
0.68%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
17.40%
RxSight, Inc. stock logo
RXST
RxSight
9.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies, Inc. stock logo
IRTC
iRhythm Technologies
1,79031.41 million31.09 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,700172.19 million169.95 millionOptionable
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
43054.82 million43.10 millionOptionable
RxSight, Inc. stock logo
RXST
RxSight
22040.49 million36.53 millionOptionable

Recent News About These Companies

RxSight, Inc. stock logo
RxSight (NASDAQ:RXST) Shares Gap Up - Here's What Happened
Morgan Stanley Sticks to Their Buy Rating for RxSight (RXST)
RxSight price target lowered to $44 from $58 at BTIG
RxSight, Inc. stock logo
RxSight (NASDAQ:RXST) Announces Earnings Results
Wells Fargo Reaffirms Their Hold Rating on RxSight (RXST)
Stifel Nicolaus Sticks to Their Hold Rating for RxSight (RXST)

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$97.77 -3.92 (-3.85%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$97.82 +0.05 (+0.05%)
As of 03/13/2025 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Envista stock logo

Envista NYSE:NVST

$16.21 -0.53 (-3.19%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$16.24 +0.04 (+0.24%)
As of 03/13/2025 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$56.03 -1.56 (-2.71%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$56.06 +0.03 (+0.06%)
As of 03/13/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

RxSight stock logo

RxSight NASDAQ:RXST

$25.22 -0.85 (-3.26%)
Closing price 03/13/2025 04:00 PM Eastern
Extended Trading
$25.89 +0.67 (+2.67%)
As of 03/13/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.